{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:32:56Z","timestamp":1792679576968,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.cmi.2019.10.031","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T20:40:49Z","timestamp":1573245649000},"page":"151-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":339,"title":["Burden of bacterial bloodstream infection\u2014a brief update on epidemiology and significance of multidrug-resistant pathogens"],"prefix":"10.1016","volume":"26","author":[{"given":"W.V.","family":"Kern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.10.031_bib1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/1469-0691.12195","article-title":"Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe","volume":"19","author":"Goto","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.10.031_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1747493016676285","article-title":"Global stroke statistics","volume":"12","author":"Thrift","year":"2017","journal-title":"Int J Stroke"},{"key":"10.1016\/j.cmi.2019.10.031_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/rth2.12101","article-title":"Current and future burden of venous thrombosis: not simply predictable","volume":"2","author":"Scheres","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.cmi.2019.10.031_bib4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","article-title":"Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals","volume":"391","author":"Conrad","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2019.10.031_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/CMR.00002-14","article-title":"Population-based epidemiology and microbiology of community-onset bloodstream infections","volume":"27","author":"Laupland","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2019.10.031_bib6","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1017\/S0950268816000613","article-title":"Burden of community-onset bloodstream infections, western interior, British Columbia, Canada","volume":"144","author":"Laupland","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.cmi.2019.10.031_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166527","article-title":"14-year survey in a Swedish county reveals a pronounced increase in bloodstream infections (BSI). Comorbidity\u2014an independent risk factor for both BSI and mortality","volume":"11","author":"Holmbom","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.10.031_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12879-017-2291-2","article-title":"Burden of bloodstream infection in an area of Mid-Norway 2002-2013: a prospective population-based observational study","volume":"17","author":"Mehl","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib9","first-page":"51","article-title":"Decreasing incidence rates of bacteremia: a 9-year population-based study","volume":"69","author":"Nielsen","year":"2014","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.10.031_bib10","article-title":"The incidence and prognosis of patients with bacteremia","volume":"62","author":"Nielsen","year":"2015","journal-title":"Dan Med J"},{"key":"10.1016\/j.cmi.2019.10.031_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013665","article-title":"Incidence of bloodstream infections: a nationwide surveillance of acute care hospitals in Switzerland 2008\u20132014","volume":"7","author":"Buetti","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2019.10.031_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/jpen.1609","article-title":"Epidemiology of infectious and noninfectious catheter complications in patients receiving home parenteral nutrition: a systematic review and meta-analysis","author":"Reitzel","year":"2019","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.cmi.2019.10.031_bib13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/QCO.0b013e32835a0d1a","article-title":"Is it possible to achieve a target of zero central line associated bloodstream infections?","volume":"25","author":"Worth","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s15010-014-0689-y","article-title":"Attributable mortality of central line associated bloodstream infection: systematic review and meta-analysis","volume":"43","author":"Ziegler","year":"2015","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2019.10.031_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1017\/ice.2015.261","article-title":"A\u00a0multicenter longitudinal study of hospital-onset bacteremia: time for a new quality outcome measure?","volume":"37","author":"Rock","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2019.10.031_bib16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1017\/ice.2018.339","article-title":"Preventability of hospital onset bacteremia and fungemia: a pilot study of a potential healthcare-associated infection outcome measure","volume":"40","author":"Dantes","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2019.10.031_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/ice.2019.40","article-title":"Hospital epidemiologists' and infection preventionists' opinions regarding hospital-onset bacteremia and fungemia as a potential healthcare-associated infection metric","volume":"40","author":"Dantes","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2019.10.031_bib18","doi-asserted-by":"crossref","first-page":"e00355","DOI":"10.1128\/AAC.00355-19","article-title":"The microbiology of bloodstream infection: 20-year trends from the SENTRY Antimicrobial Surveillance Program","volume":"63","author":"Diekema","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.10.031_bib19","article-title":"Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study","volume":"9","author":"Anderson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.10.031_bib20","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2147\/IDR.S165877","article-title":"Management and outcome of bloodstream infections: a prospective survey in 121 French hospitals (SPA-BACT survey)","volume":"11","author":"Robineau","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.cmi.2019.10.031_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/23744235.2015.1131329","article-title":"Early deaths in bloodstream infections: a population-based case series","volume":"48","author":"Kontula","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.cmi.2019.10.031_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib23","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1093\/cid\/ciy1094","article-title":"Global typhoid fever incidence: a systematic review and meta-analysis","volume":"68","author":"Marchello","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1473-3099(10)70072-4","article-title":"Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis","volume":"10","author":"Reddy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1473-3099(12)70028-2","article-title":"Community-acquired bacterial bloodstream infections in developing countries in south and southeast Asia: a systematic review","volume":"12","author":"Deen","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib26","article-title":"Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010","volume":"2","author":"Buckle","year":"2012","journal-title":"J\u00a0Glob Health"},{"key":"10.1016\/j.cmi.2019.10.031_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007187","article-title":"Increasing incidence of invasive nontyphoidal Salmonella infections in Queensland, Australia, 2007\u20132016","volume":"13","author":"Parisi","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib28","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive Salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cmi.2019.10.031_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004616","article-title":"The burden of typhoid and paratyphoid in India: systematic review and meta-analysis","volume":"10","author":"John","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178577","article-title":"Population-based incidence, seasonality and serotype distribution of invasive salmonellosis among children in Nanoro, rural Burkina Faso","volume":"12","author":"Guiraud","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.10.031_bib31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3201\/eid2106.140999","article-title":"Global burden of invasive nontyphoidal Salmonella disease","volume":"21","author":"Ao","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib32","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/civ893","article-title":"The relationship between invasive nontyphoidal Salmonella disease, other bacterial bloodstream infections, and malaria in sub-saharan Africa","volume":"62","author":"Park","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib33","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1093\/cid\/ciy1116","article-title":"Salmonella Typhi from blood cultures in the Democratic Republic of the Congo: a 10-year surveillance","volume":"68","author":"Tack","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib34","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1093\/cid\/ciy1126","article-title":"Epidemiology and antimicrobial susceptibility of Salmonella enterica bloodstream isolates among febrile children in a rural district in northeastern Tanzania: a cross-sectional study","volume":"68","author":"Msemo","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006027","article-title":"Presentation of life-threatening invasive nontyphoidal Salmonella disease in Malawian children: a prospective observational study","volume":"11","author":"MacLennan","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005118","article-title":"A\u00a0systematic review of the incidence, risk factors and case fatality rates of invasive nontyphoidal Salmonella (iNTS) disease in Africa (1966 to 2014)","volume":"11","author":"Uche","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1741-7015-12-31","article-title":"Invasive bacterial co-infection in African children with Plasmodium falciparum malaria: a systematic review","volume":"12","author":"Church","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.cmi.2019.10.031_bib38","doi-asserted-by":"crossref","first-page":"e00001","DOI":"10.1128\/CMR.00001-19","article-title":"Hypervirulent Klebsiella pneumoniae","volume":"32","author":"Russo","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2019.10.031_bib39","first-page":"e10596","article-title":"Origin, evolution, and global transmission of community-acquired Staphylococcus aureus ST8","volume":"114","author":"Strau","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cmi.2019.10.031_bib40","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41564-017-0001-x","article-title":"Clonal differences in Staphylococcus aureus bacteraemia-associated mortality","volume":"2","author":"Recker","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.cmi.2019.10.031_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz112","article-title":"Changing characteristics of Staphylococcus aureus bacteremia: results from a 21-year, prospective, longitudinal study","author":"Souli","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib42","doi-asserted-by":"crossref","first-page":"e01596","DOI":"10.1128\/mBio.01596-17","article-title":"Comparative genomic analysis of globally dominant ST131 clone with other epidemiologically successful extraintestinal pathogenic Escherichia coli (ExPEC) lineages","volume":"8","author":"Shaik","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.cmi.2019.10.031_bib43","doi-asserted-by":"crossref","first-page":"e00135","DOI":"10.1128\/CMR.00135-18","article-title":"Global extraintestinal pathogenic Escherichia coli (ExPEC) lineages","volume":"32","author":"Manges","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2019.10.031_bib44","doi-asserted-by":"crossref","first-page":"e00937","DOI":"10.1128\/AAC.00937-18","article-title":"Clinical and molecular correlates of Escherichia coli bloodstream infection from two geographically diverse centers in Rochester, Minnesota, and Singapore","volume":"62","author":"Mendis","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.10.031_bib45","doi-asserted-by":"crossref","first-page":"e00732","DOI":"10.1128\/AAC.00732-17","article-title":"Epidemic emergence in the United States of Escherichia coli sequence type 131-H30 (ST131-H30), 2000 to 2009","volume":"61","author":"Johnson","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.10.031_bib46","article-title":"Antimicrobial resistance and molecular epidemiology of Escherichia coli causing bloodstream infections in three hospitals in Shanghai, China","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.10.031_bib47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3201\/eid2501.171985","article-title":"Risk factors for Elizabethkingia acquisition and clinical characteristics of patients, South Korea","volume":"25","author":"Choi","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/cid\/cix1052","article-title":"Elizabethkingia in children: a comprehensive review of symptomatic cases reported from 1944 to 2017","volume":"67","author":"Dziuban","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2017.03.007","article-title":"Mini review: new pathogen profiles: Elizabethkingia anophelis","volume":"88","author":"Janda","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib50","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cmi.2019.03.009","article-title":"Staphylococcus capitis and NRCS-A clone: the story of an unrecognized pathogen in neonatal intensive care units","volume":"25","author":"Laurent","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.10.031_bib51","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/QCO.0b013e32833bcc8a","article-title":"Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges","volume":"23","author":"Kern","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib52","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1469-0691.2012.03903.x","article-title":"The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study","volume":"19","author":"Laupland","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.10.031_bib53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/23744235.2017.1405276","article-title":"Trends in incidence and resistance patterns of Staphylococcus aureus bacteremia","volume":"50","author":"Jokinen","year":"2018","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.cmi.2019.10.031_bib54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4269\/ajtmh.17-0631","article-title":"Staphylococcus aureus bacteremia incidence and methicillin resistance in rural Thailand, 2006\u20132014","volume":"99","author":"Jaganath","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2019.10.031_bib55","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3201\/eid2505.181773","article-title":"Age-dependent increase in incidence of Staphylococcus aureus bacteremia, Denmark, 2008\u20132015","volume":"25","author":"Thorlacius-Ussing","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib56","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-019-01330-5","article-title":"Epidemiology and outcome determinants of Staphylococcus aureus bacteremia revisited: a population-based study","author":"Lam","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2019.10.031_bib57","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/ciu508","article-title":"A\u00a0major reduction in hospital-onset Staphylococcus aureus bacteremia in Australia-12 years of progress: an observational study","volume":"59","author":"Mitchell","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib58","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1017\/ice.2015.213","article-title":"Evolving epidemiology of Staphylococcus aureus bacteremia","volume":"36","author":"Rhee","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2019.10.031_bib59","doi-asserted-by":"crossref","first-page":"214","DOI":"10.15585\/mmwr.mm6809e1","article-title":"Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections\u2014United States","volume":"68","author":"Kourtis","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2019.10.031_bib60","doi-asserted-by":"crossref","first-page":"220","DOI":"10.15585\/mmwr.mm6809e2","article-title":"Vital signs: trends in Staphylococcus aureus infections in Veterans Affairs medical centers\u2014United States, 2005\u20132017","volume":"68","author":"Jones","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2019.10.031_bib61","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/ofid\/ofy270","article-title":"Twenty-year trends in antimicrobial susceptibilities among Staphylococcus aureus from the SENTRY Antimicrobial Surveillance Program","volume":"6","author":"Diekema","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib62","article-title":"Trends in incidence of methicillin-resistant Staphylococcus aureus bloodstream infections differ by strain type and healthcare exposure, United States, 2005\u20132013","author":"See","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib63","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12879-017-2233-z","article-title":"Impact of appropriate empirical antibiotic treatment on recurrence and mortality in patients with bacteraemia: a population-based cohort study","volume":"17","author":"Gradel","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib64","first-page":"242","article-title":"Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies","volume":"68","author":"Kaasch","year":"2014","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.10.031_bib65","first-page":"516","article-title":"Survival following Staphylococcus aureus bloodstream infection: a prospective multinational cohort study assessing the impact of place of care","volume":"77","author":"Nambiar","year":"2018","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.10.031_bib66","doi-asserted-by":"crossref","first-page":"948.e1","DOI":"10.1016\/j.cmi.2016.07.034","article-title":"Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study","volume":"22","author":"Braquet","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.10.031_bib67","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1473-3099(14)70876-X","article-title":"A\u00a0comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study","volume":"14","author":"Yaw","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib68","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jamainternmed.2017.3958","article-title":"Association of evidence-based care processes with mortality in Staphylococcus aureus bacteremia at Veterans Health Administration hospitals, 2003\u20132014","volume":"177","author":"Goto","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2019.10.031_bib69","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/jac\/dky556","article-title":"Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia","volume":"74","author":"Perez-Rodriguez","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.10.031_bib70","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw048","article-title":"The impact of infectious disease specialist consultation for Staphylococcus aureus bloodstream infections: a systematic review","volume":"3","author":"Paulsen","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib71","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/cid\/civ120","article-title":"Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study","volume":"60","author":"Bai","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib72","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/cid\/ciy739","article-title":"A\u00a0prognostic model of persistent bacteremia and mortality in complicated Staphylococcus aureus bloodstream infection","volume":"68","author":"Guimaraes","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz126","article-title":"Prognostic power of pathogen cell-free DNA in Staphylococcus aureus bacteremia","volume":"6","author":"Guimaraes","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib74","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1086\/432472","article-title":"Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection","volume":"41","author":"Khatib","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib75","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib76","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jac\/dkq424","article-title":"Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge","volume":"66","author":"Wolkewitz","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.10.031_bib77","doi-asserted-by":"crossref","first-page":"30319","DOI":"10.2807\/1560-7917.ES.2016.21.33.30319","article-title":"The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study","volume":"21","author":"Stewardson","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2019.10.031_bib78","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz123","article-title":"Methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia\u2014nationwide estimates of 30-day readmission, in-hospital mortality, length of stay, and cost in the US","author":"Inagaki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/cid\/ciy399","article-title":"National costs associated with methicillin-susceptible and methicillin-resistant Staphylococcus aureus hospitalizations in the United States, 2010\u20132014","volume":"68","author":"Klein","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib80","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jhin.2016.12.008","article-title":"Epidemiology of Escherichia coli bacteraemia in England: results of an enhanced sentinel surveillance programme","volume":"95","author":"Abernethy","year":"2017","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2019.10.031_bib81","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.35.30329","article-title":"Descriptive epidemiology of Escherichia coli bacteraemia in England, april 2012 to march 2014","volume":"21","author":"Bou-Antoun","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2019.10.031_bib82","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jhin.2018.10.024","article-title":"Factors that impact on the burden of Escherichia coli bacteraemia: multivariable regression analysis of 2011\u20132015 data from West London","volume":"101","author":"Blandy","year":"2019","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2019.10.031_bib83","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/1471-2334-13-385","article-title":"Population-based incidence and comparative demographics of community-associated and healthcare-associated Escherichia coli bloodstream infection in Auckland, New Zealand, 2005\u20132011","volume":"13","author":"Williamson","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib84","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-019-01180-3","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: update on molecular epidemiology and treatment options","author":"Peirano","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.cmi.2019.10.031_bib85","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijantimicag.2016.12.013","article-title":"Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes","volume":"49","author":"Morales-Barroso","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2019.10.031_bib86","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1017\/ice.2018.63","article-title":"Comparison of predictors and mortality between bloodstream infections caused by ESBL-producing Escherichia coli and ESBL-producing Klebsiella pneumoniae","volume":"39","author":"Scheuerman","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2019.10.031_bib87","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s15010-014-0670-9","article-title":"Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K.\u00a0pneumoniae and E.\u00a0coli: an analysis of the disease burden in a large cohort","volume":"42","author":"Leistner","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2019.10.031_bib88","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/669086","article-title":"Burden of bloodstream infection caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model","volume":"34","author":"Stewardson","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2019.10.031_bib89","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/jac\/dkq412","article-title":"Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins","volume":"66","author":"de Kraker","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.10.031_bib90","doi-asserted-by":"crossref","first-page":"e01709","DOI":"10.1128\/AAC.01709-16","article-title":"Increased costs associated with bloodstream infections caused by multidrug-resistant gram-negative bacteria are due primarily to patients with hospital-acquired infections","volume":"61","author":"Thaden","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.10.031_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001104","article-title":"Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe","volume":"8","author":"de Kraker","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.cmi.2019.10.031_bib92","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib93","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s10096-018-3292-9","article-title":"Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007\u20132015)","volume":"37","author":"de Angelis","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib94","series-title":"Central asian and eastern European surveillance of antimicrobial resistance. Annual report 2017","year":"2018"},{"key":"10.1016\/j.cmi.2019.10.031_bib95","doi-asserted-by":"crossref","first-page":"e01882","DOI":"10.1128\/AAC.01882-17","article-title":"Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from the China CRE Network","volume":"62","author":"Zhang","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.10.031_bib96","doi-asserted-by":"crossref","first-page":"e02349","DOI":"10.1128\/AAC.02349-16","article-title":"Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE epicenter of the United States","volume":"61","author":"Satlin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.10.031_bib97","doi-asserted-by":"crossref","first-page":"e00052","DOI":"10.1128\/mSphere.00052-19","article-title":"A\u00a0cohort study of the impact of carbapenem-resistant Enterobacteriaceae infections on mortality of patients presenting with sepsis","volume":"4","author":"Sabino","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.cmi.2019.10.031_bib98","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13756-019-0499-1","article-title":"Shifting trends and age distribution of ESKAPEEc resistance in bloodstream infection, Southwest China, 2012\u20132017","volume":"8","author":"Yang","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.cmi.2019.10.031_bib99","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13756-019-0545-z","article-title":"Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998\u20132017)","volume":"8","author":"Tian","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.cmi.2019.10.031_bib100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijid.2016.08.002","article-title":"Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008\u20132014","volume":"50","author":"Gandra","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib101","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/20477724.2017.1340128","article-title":"Carbapenem-resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience","volume":"111","author":"Veeraraghavan","year":"2017","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.cmi.2019.10.031_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2019.06.010","article-title":"Antimicrobial resistance in South Korea: a report from the Korean global antimicrobial resistance surveillance system (Kor-GLASS) for 2017","author":"Liu","year":"2019","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.cmi.2019.10.031_bib103","first-page":"24","article-title":"Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU\/EEA","author":"Jarlier","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2019.10.031_bib104","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1017\/ice.2017.197","article-title":"Carbapenem resistance, initial antibiotic therapy, and mortality in Klebsiella pneumoniae bacteremia: a systematic review and meta-analysis","volume":"38","author":"Kohler","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2019.10.031_bib105","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","article-title":"Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study","volume":"17","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib106","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jiph.2018.08.002","article-title":"Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital","volume":"12","author":"Li","year":"2019","journal-title":"J\u00a0Infect Public Health"},{"key":"10.1016\/j.cmi.2019.10.031_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123706","article-title":"Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance study","volume":"10","author":"Lanini","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.10.031_bib108","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ajh.24489","article-title":"Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey","volume":"91","author":"Trecarichi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cmi.2019.10.031_bib109","first-page":"668","article-title":"Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis","volume":"72","author":"Righi","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.10.031_bib110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/21505594.2016.1213472","article-title":"Carbapenem-resistant Enterobacteriaceae in special populations: solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies","volume":"8","author":"Pouch","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.cmi.2019.10.031_bib111","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(18)30792-8","article-title":"Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study","volume":"19","author":"Stewardson","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.031_bib112","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015365","article-title":"EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA): a protocol of a European multicentre observational study","volume":"7","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2019.10.031_bib113","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/1740774515626362","article-title":"Efficiencies of platform clinical trials: a vision of the future","volume":"13","author":"Saville","year":"2016","journal-title":"Clin Trial."},{"key":"10.1016\/j.cmi.2019.10.031_bib114","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/cpt.514","article-title":"PIPELINEs: creating comparable clinical knowledge efficiently by linking trial platforms","volume":"100","author":"Trusheim","year":"2016","journal-title":"Clin Pharmacol Ther"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19305865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19305865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:24:27Z","timestamp":1761117867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19305865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1198743X19305865"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.10.031","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burden of bacterial bloodstream infection\u2014a brief update on epidemiology and significance of multidrug-resistant pathogens","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}